Filing Details

Accession Number:
0001415889-23-015508
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-27 18:00:17
Reporting Period:
2023-11-22
Accepted Time:
2023-11-27 18:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1798749 Aerovate Therapeutics Inc. AVTE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168060 Ralph Niven C/O Aerovate Therapeutics, Inc.
930 Winter Street, Suite M-500
Waltham MA 02451
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-22 4,200 $1.74 5,809 No 4 M Direct
Common Stock Acquisiton 2023-11-22 9,600 $2.14 15,409 No 4 M Direct
Common Stock Disposition 2023-11-22 13,800 $15.00 1,609 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-11-22 2,700 $0.00 2,700 $1.74
Common Stock Stock Option (Right to Buy) Disposition 2023-11-22 1,500 $0.00 1,500 $1.74
Common Stock Stock Option (Right to Buy) Disposition 2023-11-22 1,500 $0.00 1,500 $2.14
Common Stock Stock Option (Right to Buy) Disposition 2023-11-22 3,600 $0.00 3,600 $2.14
Common Stock Stock Option (Right to Buy) Disposition 2023-11-22 4,500 $0.00 4,500 $2.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,008 2030-09-03 No 4 M Direct
10,588 2030-09-03 No 4 M Direct
12,394 2031-04-01 No 4 M Direct
38,508 2031-04-01 No 4 M Direct
46,232 2031-04-01 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
  2. A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
  3. A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
  4. A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021.
  5. A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021.
  6. A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021.